Record Details

Catalog Search

Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.

Image of item

Available copies

  • 1 of 1 copy available at Evergreen Indiana.

Current holds

0 current holds with 1 total copy.

Location Call Number / Copy Notes Barcode Shelving Location Status Due Date
Indiana State Library - Indianapolis ISLM Y 4.C 73/8:113-132 (Text) 00000106193378 General Federal documents Available -

Record details

  • Physical Description: v, 146 pages ; 24 cm
  • Publisher: Washington : U.S. Government Publishing Office, 2016.
  • Distributor: Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office

Content descriptions

General Note:
Shipping list no.: 2016-0217-P.
"Serial No. 113-132."
Bibliography, etc. Note:
Includes bibliographical references.
Subject: Generic drugs > Labeling > United States.
Drugs > Safety regulations > United States.
Warning labels > Government policy > United States.

Additional Resources